HomeAI · summaries
Storia in 3 fonti
Roche’s Lung Cancer Pill Outperforms Rival Drugs in Late Trial
(Bloomberg) -- Roche Holding AG’s experimental lung cancer pill outperformed two approved medicines in a late-stage study, boosting the Swiss drugmaker’s bid to bring a next-generation treatment to market.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Roche KRAS drug succeeds in head-to-head lung cancer study
The Phase 3 trial compared Roche’s divarasib with treatments sold by Amgen and Bristol Myers in patients with non-small cell lung cancer.
- ·
swissinfo.ch
Roche claims clinical trial success for lung cancer drug
Swiss pharmaceutical and diagnostics giant Roche announced the success of a pivotal clinical trial for its drug divarasib in the treatment of a form of lung cancer.
